Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design
Movement Disorders · 2024-01 · 39 (1) · 141-151
DOI: 10.1002/mds.29651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 14.11.2023. Verfasst von Jussi Pekka Tolonen und 48 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Movement Disorders, Carbonic Anhydrases, Intellectual Disability. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, H2020 Excellent Science.
Abstract (Originalsprache)
Background
The ITPR1 gene encodes the inositol 1,4,5‐trisphosphate (IP 3 ) receptor type 1 (IP 3 R1), a critical player in cerebellar intracellular calcium signaling. Pathogenic missense variants in ITPR1 cause congenital spinocerebellar ataxia type 29 (SCA29), Gillespie syndrome (GLSP), and severe pontine/cerebellar hypoplasia. The pathophysiological basis of the different phenotypes is poorly understood.
Objectives
We aimed to identify novel SCA29 and GLSP cases to define core phenotypes, describe the spectrum of missense variation across ITPR1 , standardize the ITPR1 variant nomenclature, and investigate disease progression in relation to cerebellar atrophy.
Methods
Cases were identified using next‐generation sequencing through the Deciphering Developmental Disorders study, the 100,000 Genomes project, and clinical collaborations. ITPR1 alternative splicing in the human cerebellum was investigated by quantitative polymerase chain reaction.
Results
We report the largest, multinational case series of 46 patients with 28 unique ITPR1 missense variants. Variants clustered in functional domains of the protein, especially in the N‐terminal IP 3 ‐binding domain, the carbonic anhydrase 8 (CA8)‐binding region, and the C‐terminal transmembrane channel domain. Variants outside these domains were of questionable clinical significance. Standardized transcript annotation, based on our ITPR1 transcript expression data, greatly facilitated analysis. Genotype–phenotype associations were highly variable. Importantly, while cerebellar atrophy was common, cerebellar volume loss did not correlate with symptom progression.
Conclusions
This dataset represents the largest cohort of patients with ITPR1 missense variants, expanding the clinical spectrum of SCA29 and GLSP. Standardized transcript annotation is essential for future reporting. Our findings will aid in diagnostic interpretation in the clinic and guide selection of variants for preclinical studies. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Kavli Institute of Nanoscience Discovery, University of Oxford, Oxford, UK.
- Oxford Center for Genomic Medicine, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford, Oxford, UK.
- Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
- South West Regional Genetics Service, St. George's University Hospitals, London, UK.
- Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, UK.
ORCID-Profile: Jussi Pekka Tolonen, Ricardo Parolin Schnekenberg, George K Tofaris, Henry Houlden, Alexander J M Blakes, Esther B E Becker, Andrea H Németh
Förderung
- Wellcome Trust
- Medical Research Council
- H2020 Excellent Science
- University of Oxford
- Ataxia UK
- Henry Smith Charity
- Orionin Tutkimussäätiö
- Sigrid Juséliuksen Säätiö
Zitieren
APA
Tolonen, J. P., Parolin Schnekenberg, R., McGowan, S., Sims, D., McEntagart, M., Elmslie, F., Shears, D., Stewart, H., Tofaris, G. K., Dabir, T., Morrison, P. J., Johnson, D., Hadjivassiliou, M., Ellard, S., Shaw-Smith, C., Znaczko, A., Dixit, A., Suri, M., Sarkar, A., …, & Németh, A. H. (2024). Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design. Movement Disorders, 39(1), 141-151. https://doi.org/10.1002/mds.29651
Vancouver
Tolonen JP, Parolin Schnekenberg R, McGowan S, Sims D, McEntagart M, Elmslie F, et al. Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design. Movement Disorders. 2024;39(1):141-151. doi:10.1002/mds.29651
BibTeX
@article{Tolonen2024,
author = {Tolonen, Jussi Pekka and Parolin Schnekenberg, Ricardo and McGowan, Simon and Sims, David and McEntagart, Meriel and Elmslie, Frances and Shears, Debbie and Stewart, Helen and Tofaris, George K and Dabir, Tabib and Morrison, Patrick J and Johnson, Diana and Hadjivassiliou, Marios and Ellard, Sian and Shaw-Smith, Charles and Znaczko, Anna and Dixit, Abhijit and Suri, Mohnish and Sarkar, Ajoy and Harrison, Rachel E and Jones, Gabriela and Houlden, Henry and Ceravolo, Giorgia and Jarvis, Joanna and Williams, Jonathan and Shanks, Morag E and Clouston, Penny and Rankin, Julia and Blumkin, Lubov and Lerman-Sagie, Tally and Ponger, Penina and Raskin, Salmo and Granath, Katariina and Uusimaa, Johanna and Conti, Hector and McCann, Emma and Joss, Shelagh and Blakes, Alexander J M and Metcalfe, Kay and Kingston, Helen and Bertoli, Marta and Kneen, Rachel and Lynch, Sally Ann and Martínez Albaladejo, Inmaculada and Moore, Austen Peter and Jones, Wendy D and Genomics England Research Consortium, Genomics England Research Consortium and Becker, Esther B E and Németh, Andrea H},
title = {Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {1},
pages = {141--151},
doi = {10.1002/mds.29651}
}
EUVIMED